Skip to main content
. 2020 Oct 2;85:153364. doi: 10.1016/j.phymed.2020.153364

Fig. 8.

Fig 8

Molecular docking of active compounds with SARS-CoV S1 subunit. A represents binding position of all the five active compounds within RBD. B to F exhibit interaction mode of ginsenoside Ra2 (ZZY-8), ginsenoside Rb1 (ZZY-9), ginsenoside Rb3 (ZZY-13), glycyrrhizic acid (ZZY-44), berberine chloride (ZZY-54) with RBD domain, respectively.